Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
182.08
+3.91 (2.19%)
At close: Jun 26, 2026, 4:00 PM EDT
182.85
+0.77 (0.42%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $38.71 billion as of June 26, 2026. Its market cap has increased by 409.48% in one year.
Market Cap
38.71B
Enterprise Value
37.24B
1-Year Change
409.48%
Ranking
Category
Stock Price
$182.08
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $38.71B, an increase of 2,253.91%. That is a compound annual growth rate of 64.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 38.71B | 151.39% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 63.09B |
| argenx SE | 55.35B |
| Alnylam Pharmaceuticals | 39.14B |
| Royalty Pharma | 31.49B |
| BeOne Medicines AG | 30.61B |
| Roivant Sciences | 24.47B |
| Moderna | 23.71B |
| BioNTech SE | 22.76B |